We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENJYW
2476
CALL
DELISTED
Enjoy Technology, Inc. Warrant
ENJYW
$908K ﹤0.01%
239,477
FLZH
2477
Flash Sports & Media Holdings
FLZH
$66.9M
$907K ﹤0.01%
3,373
-822
-20% -$205K
ATAQ.WS
2478
CALL
DELISTED
Altimar Acquisition Corp III Warrants
ATAQ.WS
$907K ﹤0.01%
92,743
REGI
2479
DELISTED
Renewable Energy Group, Inc.
REGI
$905K ﹤0.01%
+14,929
New +$723K
RAM
2480
DELISTED
Aries I Acquisition Corporation Class A Ordinary Share
RAM
$903K ﹤0.01%
89,613
GDYN icon
2481
Grid Dynamics Holdings
GDYN
$569M
$899K ﹤0.01%
+63,816
New +$1.3M
C icon
2482
CALL
Citigroup
C
$213B
$897K ﹤0.01%
+16,800
New +$1.04M
EGY icon
2483
Vaalco Energy
EGY
$562M
$894K ﹤0.01%
136,906
-148,443
-52% -$777K
DNA.WS
2484
CALL
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$890K ﹤0.01%
220,120
+20,124
+10% +$22.4K
SONDW
2485
CALL
DELISTED
Sonder Holdings Inc Warrants
SONDW
$885K ﹤0.01%
186,546
-13,445
-7% -$14.2K
MLAB icon
2486
Mesa Laboratories
MLAB
$551M
$881K ﹤0.01%
3,461
-222
-6% -$60.3K
ME
2487
DELISTED
23andMe Holding Co
ME
$876K ﹤0.01%
11,434
+7,604
+199% +$694K
CBRL icon
2488
Cracker Barrel
CBRL
$1.26B
$874K ﹤0.01%
7,363
-679
-8% -$84.2K
MIMO.WS
2489
CALL
DELISTED
Airspan Networks Holdings Inc Warrants
MIMO.WS
$874K ﹤0.01%
300,000
IIN
2490
DELISTED
IntriCon Corporation
IIN
$872K ﹤0.01%
36,602
+30,410
+491% +$574K
ISBC
2491
DELISTED
Investors Bancorp, Inc.
ISBC
$872K ﹤0.01%
58,438
-100,242
-63% -$1.64M
KLR
2492
DELISTED
Kaleyra, Inc.
KLR
$870K ﹤0.01%
41,568
+37,933
+1,044% +$1.05M
LESL icon
2493
Leslie's
LESL
$8.33M
$869K ﹤0.01%
2,246
-71,734
-97% -$29.8M
SCI icon
2494
Service Corp International
SCI
$11.8B
$868K ﹤0.01%
13,187
-118,203
-90% -$7.44M
DOUG icon
2495
Douglas Elliman
DOUG
$156M
$866K ﹤0.01%
+124,593
New +$945K
IBRX icon
2496
ImmunityBio
IBRX
$7.15B
$861K ﹤0.01%
153,282
-90,237
-37% -$554K
GLEO.WS
2497
CALL
DELISTED
Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share
GLEO.WS
$857K ﹤0.01%
300,000
HII icon
2498
Huntington Ingalls Industries
HII
$11B
$852K ﹤0.01%
+4,269
New +$833K
XLV icon
2499
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
$849K ﹤0.01%
6,200
+1,100
+22% +$146K
IOVA icon
2500
Iovance Biotherapeutics
IOVA
$2.04B
$848K ﹤0.01%
50,953
-810,207
-94% -$12.5M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.